Anders Johnsson
11 – 20 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin
(
- Contribution to journal › Article
-
Mark
Determinants for local tumour control probability after radiotherapy of anal cancer
(
- Contribution to journal › Article
-
Mark
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Occupational sedentariness and breast cancer risk
(
- Contribution to journal › Article
-
Mark
Swelling and mass transport properties of nanocellulose-HPMC composite films
(
- Contribution to journal › Article
-
Mark
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Drug costs and benefits of medical treatments in high-unmet need solid tumours in the Nordic countries
(
- Contribution to journal › Article